Submission Deadline 06/15/2028
Fiscal Capacity $50,135,013
| Opportunity Number | RFA-OD-27-005 |
|---|---|
| Agency | HHS-NIH11 |
| Application Deadline | 06/15/2028 |
| Award Amount | $50,135,013 |
| Status | Posted |
| Sector | Health |
| Cost Sharing | Not Required |
Fiscal Parameters & Taxonomy
Authority HHS-NIH11
Status Posted
Who Can Apply
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) State governments Independent school districts Others (see text field entitled "Additional Information on Eligibility" for clarification) City or township governments County governments Native American tribal governments (Federally recognized) Special district governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities For profit organizations other than small businesses Small businesses
Eligibility Intelligence
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Program Description
The NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project seeks to improve health and quality-of-life for individuals with Down syndrome. The purpose of this Notice of Funding Opportunity (NOFO) encourages Exploratory/Developmental Phased Innovation (R61/R33) grant applications to support development of clinical trials to treat critical and co-occurring health conditions in individuals with Down syndrome. The proposed research aims should be milestone-driven. The total project period for an application submitted in response to this NOFO may not exceed five years. This NOFO provides support for up to two years (R61 phase) for preliminary/developmental/planning studies, followed by possible transition to clinical trial support (R33) of up to three years, although the total duration of the award may not exceed five years. This NOFO requires measurable R61 milestones.
CFDA Programs
93.173 Research Related to Deafness and Communication Disorders
93.233 National Center on Sleep Disorders Research
93.310 Trans-NIH Research Support
93.350 National Center for Advancing Translational Sciences
93.395 Cancer Treatment Research
93.837 Cardiovascular Diseases Research
93.838 Lung Diseases Research
93.839 Blood Diseases and Resources Research
93.840 Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders
93.846 Arthritis, Musculoskeletal and Skin Diseases Research
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
93.865 Child Health and Human Development Extramural Research
93.866 Aging Research
Agency Contact
The INCLUDE Project DownSyndromeINCLUDE@mail.nih.gov
✉ DownSyndromeINCLUDE@mail.nih.gov📞 301-402-2541
Related Intelligence Guides
In-depth editorial guides covering this agency's programs, eligibility requirements, and application strategies.